Surgery Partners, Inc. (SGRY)

Over the past six months, Surgery Partners, Inc.'s stock has been impacted by several events. The company appointed Lloyd Dean to its Board of Directors and presented at an investor conference in March 2026. Surgery Partners announced its fourth-quarter and full-year 2025 results, provided 2026 guidance, and initiated a share repurchase program. The fourth-quarter 2025 earnings per share (EPS) missed analysts' expectations. The company noted softer-than-expected same-facility volume growth during its Q3 2025 earnings call and adjusted its fourth-quarter outlook. The company's stock price has decreased, and there has been significant insider selling. Short interest in Surgery Partners recently decreased.

Surgery Partners, Inc. experiences some demand seasonality for its services, with a typical seasonal lift in commercial volumes during the fourth quarter. The healthcare industry, including outpatient services, is experiencing growth driven by factors such as an aging population, a rising prevalence of chronic diseases, and a shift towards value-based care models.

Surgery Partners, Inc. (SGRY) is a healthcare services company operating a national network of surgical facilities and ancillary services. It specializes in managing and owning ambulatory surgery centers (ASCs), surgical hospitals, and multispecialty rehabilitation hospitals in the United States. The company's services include non-emergency surgical procedures across various specialties and ancillary services such as physician practices, anesthesia, urgent care, imaging, lab testing, infusion therapy, and rehabilitation.

Surgery Partners, Inc. operates in over 250 locations across 30 states in the United States. These locations include ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities.

Surgery Partners, Inc. has maintained a strong brand reputation, characterized by brand recognition and physician engagement. The company is known for delivering high-quality, cost-effective surgical and ancillary care. Its integrated outpatient delivery model supports patients and physicians, fostering strategic partnerships with healthcare providers. The company's focus on patient care and clinical outcomes has positioned it as a preferred partner for physicians.

Surgery Partners, Inc. has a diverse ownership structure, with a substantial portion held by institutional investors. Major institutional owners include Bain Capital Investors Llc, Janus Henderson Group Plc, King Street Capital Management, L.p., Pentwater Capital Management LP, UBS Group AG, Vanguard Group Inc, Fmr Llc, BlackRock, Inc., Dimensional Fund Advisors Lp, and Clearbridge Investments, LLC. Bain Capital Private Equity LP is a significant shareholder. Individual investors and insiders also hold shares in the company.